Development of a stable Gaussia luciferase enterovirus 71 reporter virus.

[1]  P. Shi,et al.  Inhibition of Enterovirus 71 by Adenosine Analog NITD008 , 2014, Journal of Virology.

[2]  T. Ma,et al.  Identification of Luteolin as Enterovirus 71 and Coxsackievirus A16 Inhibitors through Reporter Viruses and Cell Viability-Based Screening , 2014, Viruses.

[3]  G. Wang,et al.  Activation of Peripheral Blood Mononuclear Cells by Dengue Virus Infection Depotentiates Balapiravir , 2013, Journal of Virology.

[4]  Wenbo Xu,et al.  Development and characterization of a stable eGFP enterovirus 71 for antiviral screening. , 2013, Antiviral research.

[5]  J. Neyts,et al.  Combating enterovirus replication: state-of-the-art on antiviral research. , 2012, Biochemical pharmacology.

[6]  P. Phuektes,et al.  Modification of the Untranslated Regions of Human Enterovirus 71 Impairs Growth in a Cell-Specific Manner , 2011, Journal of Virology.

[7]  H. Kung,et al.  Viral kinetics of enterovirus 71 in human abdomyosarcoma cells. , 2011, World journal of gastroenterology.

[8]  Li Guo,et al.  Crystal Structures of Enterovirus 71 3C Protease Complexed with Rupintrivir Reveal the Roles of Catalytically Important Residues , 2011, Journal of Virology.

[9]  J. Chu,et al.  Developments towards antiviral therapies against enterovirus 71 , 2010, Drug Discovery Today.

[10]  M. Shimojima,et al.  Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71 , 2009, Nature Medicine.

[11]  S. Koike,et al.  Scavenger receptor B2 is a cellular receptor for enterovirus 71 , 2009, Nature Medicine.

[12]  B. Tannous,et al.  Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo , 2009, Nature Protocols.

[13]  E. De Clercq,et al.  Mutations in the Nonstructural Protein 3A Confer Resistance to the Novel Enterovirus Replication Inhibitor TTP-8307 , 2009, Antimicrobial Agents and Chemotherapy.

[14]  D. Ferguson,et al.  High-Throughput Assays Using a Luciferase-Expressing Replicon, Virus-Like Particles, and Full-Length Virus for West Nile Virus Drug Discovery , 2005, Antimicrobial Agents and Chemotherapy.

[15]  A. Paul,et al.  Identification of an RNA Hairpin in Poliovirus RNA That Serves as the Primary Template in the In Vitro Uridylylation of VPg , 2000, Journal of Virology.

[16]  E. Wimmer,et al.  Characterization of the Nucleoside Triphosphatase Activity of Poliovirus Protein 2C Reveals a Mechanism by Which Guanidine Inhibits Poliovirus Replication* , 1999, The Journal of Biological Chemistry.

[17]  D. R. Tershak,et al.  Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C , 1989, Journal of virology.